| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 357.185.553 $ | +15.653.493 $ | +11,8 % | 275.917.668 $ | -181.225.811 $ | +8,6 % | 942.950.844 $ | -157.909.597 $ | +40,3 % | |
| Capital World Investors | 205.972.101 $ | -5.113.288 $ | -2,4 % | ||||||
| FMR LLC | 25.408.762 $ | -133.932.224 $ | -84,1 % | 159.340.986 $ | -57.382.896 $ | -26,5 % | |||
| RTW INVESTMENTS, LP | 123.657.542 $ | +900.218 $ | +0,7 % | 122.757.324 $ | +45.102.727 $ | +58,1 % | 77.654.597 $ | -115.969.957 $ | -59,9 % |
| Clearbridge Investments, LLC | 31.893.740 $ | -87.376.606 $ | -73,3 % | 119.270.346 $ | -21.027.741 $ | -15,0 % | |||
| RA CAPITAL MANAGEMENT, L.P. | 107.353.598 $ | ||||||||
| Janus Henderson Group Ltd. | 69.486.679 $ | -7.349.277 $ | -9,6 % | ||||||
| WELLINGTON MANAGEMENT GROUP LLP | 58.238.440 $ | +10.086.043 $ | +20,9 % | ||||||
| Frazier Life Sciences Management, L.P. | 35.782.639 $ | +2.225.714 $ | +6,6 % | 33.556.925 $ | -21.592.950 $ | -39,2 % | 55.149.875 $ | +9.404.289 $ | +20,6 % |
| BAMCO INC /NY/ | 31.192.962 $ | +6.179.354 $ | +24,7 % | 46.471.425 $ | -9.054.431 $ | -16,3 % | |||
| CITADEL ADVISORS LLC | 32.387.659 $ | +1.525.667 $ | +4,9 % | 30.861.992 $ | -4.476.568 $ | -12,7 % | 35.338.560 $ | +20.626.226 $ | +140,2 % |
| PRICE T ROWE ASSOCIATES INC /MD/ | 32.151.000 $ | +26.799.000 $ | +500,7 % | ||||||
| UBS Group AG | 31.438.925 $ | +21.049.810 $ | +202,6 % | ||||||
| ADAR1 Capital Management, LLC | 26.811.153 $ | +4.822.540 $ | +21,9 % | 29.442.954 $ | -296.828 $ | -1,0 % | |||
| Allianz Asset Management GmbH | 27.620.350 $ | -4.971.690 $ | -15,3 % | ||||||
| Rock Springs Capital Management LP | 26.813.531 $ | -3.659.047 $ | -12,0 % | ||||||
| 357.185.553 $ | +15.653.493 $ | +11,8 % | 275.917.668 $ | -181.225.811 $ | +8,6 % | 942.950.844 $ | -157.909.597 $ | +40,3 % | |